These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36692387)

  • 1. Practical Management of HRS-AKI in the Era of Terlipressin: What the Gastroenterologist Needs to Know.
    Wong F; Kwo P
    Am J Gastroenterol; 2023 Jun; 118(6):915-920. PubMed ID: 36692387
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome.
    Wong F; Boyer TD; Sanyal AJ; Pappas SC; Escalante S; Jamil K
    Nephrol Dial Transplant; 2020 Sep; 35(9):1554-1561. PubMed ID: 30887050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatorenal Syndrome: Pathophysiology, Diagnosis, and Treatment.
    Belcher JM
    Med Clin North Am; 2023 Jul; 107(4):781-792. PubMed ID: 37258014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival.
    Solé C; Solà E; Huelin P; Carol M; Moreira R; Cereijo U; Mas JM; Graupera I; Pose E; Napoleone L; dePrada G; Juanola A; Fabrellas N; Torres F; Morales-Ruiz M; Farrés J; Jiménez W; Ginès P
    Liver Int; 2019 Jul; 39(7):1246-1255. PubMed ID: 30597709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome.
    Piano S; Gambino C; Vettore E; Calvino V; Tonon M; Boccagni P; Gringeri E; Germani G; Burra P; Cillo U; Angeli P
    Hepatology; 2021 May; 73(5):1909-1919. PubMed ID: 32870499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory events with terlipressin and albumin in hepatorenal syndrome: A review and clinical guidance.
    Allegretti AS; Subramanian RM; Francoz C; Olson JC; Cárdenas A
    Liver Int; 2022 Oct; 42(10):2124-2130. PubMed ID: 35838488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terlipressin plus albumin in patients with HRS listed for liver transplant: Treat early and avoid RRT.
    Juanola A; Cárdenas A
    Liver Transpl; 2024 Apr; 30(4):335-336. PubMed ID: 38100174
    [No Abstract]   [Full Text] [Related]  

  • 8. The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.
    Flamm SL; Brown K; Wadei HM; Brown RS; Kugelmas M; Samaniego-Picota M; Burra P; Poordad F; Saab S
    Liver Transpl; 2021 Aug; 27(8):1191-1202. PubMed ID: 33848394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence.
    Zhang J; Rössle M; Zhou X; Deng J; Liu L; Qi X
    Curr Med Res Opin; 2019 May; 35(5):859-868. PubMed ID: 30474439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress of terlipressin in the treatment of cirrhotic ascites-related complications].
    Liu CH; Xing F; Wang J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):929-932. PubMed ID: 31941255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward.
    Belcher JM; Parada XV; Simonetto DA; Juncos LA; Karakala N; Wadei HM; Sharma P; Regner KR; Nadim MK; Garcia-Tsao G; Velez JCQ; Parikh SM; Chung RT; Allegretti AS;
    Am J Kidney Dis; 2022 May; 79(5):737-745. PubMed ID: 34606933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MODIFIED TREATMENT OF HEPATORENAL SYNDROME TYPE I DEPENDING ON THE STAGE OF ACUTE KIDNEY INJURY.
    Slyvka N; Rusnak I; Zub L; Kulachek Y; Kulachek V; Al Salama M; Rovinskyi O
    Georgian Med News; 2021 May; (314):125-128. PubMed ID: 34248041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure.
    Arora V; Maiwall R; Rajan V; Jindal A; Muralikrishna Shasthry S; Kumar G; Jain P; Sarin SK
    Hepatology; 2020 Feb; 71(2):600-610. PubMed ID: 30076614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring Renal Function and Therapy of Hepatorenal Syndrome Patients with Cirrhosis.
    Juanola A; Solé C; Toapanta D; Ginès P; Solà E
    Clin Liver Dis; 2021 May; 25(2):441-460. PubMed ID: 33838860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of treatment with terlipressin plus albumin in hepatorenal syndrome diagnosed with the new acute kidney injury versus the conventional criteria.
    Kalambokis GN; Christaki M; Tsiakas I; Despotis G; Milionis HJ
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1292-1294. PubMed ID: 31498285
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: CON.
    Willows J; Hiremath S
    Kidney360; 2024 Jun; 5(6):795-798. PubMed ID: 38526155
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: COMMENTARY.
    Allegretti AS
    Kidney360; 2024 Jun; 5(6):799-801. PubMed ID: 38526154
    [No Abstract]   [Full Text] [Related]  

  • 18. End-stage liver disease: Management of hepatorenal syndrome.
    Mauro E; Garcia-Olveira L; Gadano A
    Liver Int; 2021 Jun; 41 Suppl 1():119-127. PubMed ID: 34155791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatorenal syndrome.
    Ginès P; Solà E; Angeli P; Wong F; Nadim MK; Kamath PS
    Nat Rev Dis Primers; 2018 Sep; 4(1):23. PubMed ID: 30213943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies in terlipressin and transplantation in the United States: How do we MELD the two?
    Przybyszewski EM; Wilechansky RM; McLean Diaz P; Allegretti AS; VanWagner LB; Cullaro G; Levitsky J; Ginès P; Piano S; Asrani SK; Patidar KR;
    Liver Transpl; 2024 Jul; 30(7):753-759. PubMed ID: 38537069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.